Kazia Therapeutics Cash Flow Statement (2009-2025) | KZIA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2009	Dec2010	Dec2011	Dec2016	Dec2017	Dec2018	Jun2019	Dec2019	Jun2020	Dec2020	Dec2021	Dec2022	Jun2025	Dec2025
Operating Activities
Net Income (Quarter)	-5.81M	-5.14M	-0.93M
Share-based Compensation (Quarter)										0.22M
Gains from Sales and Divestitures (Quarter)	0.03M
Gains from Investment Securities (Quarter)					0.50M					0.08M
Asset Writedowns and Impairment (Quarter)	0.99M
Non-cash Items (Quarter)				-2.42M	-4.81M	-3.00M		-3.24M
Cash from Operations (Quarter)								-1.87M		-8.97M	-8.30M	-5.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)				0.38M	0.61M	0.39M
Amortization (Quarter)	8.30M	1.99M	2.03M				2.60M	2.43M	2.24M	2.39M			0.09M	0.23M
Depreciation & Amortization (CF) (Quarter)	-0.26M	-0.20M	-0.08M		0.77M					0.40M
Change in Working Capital
Change in Receivables (Quarter)										0.73M	0.01M
Change in Account Payables (Quarter)										-0.45M		-0.40M
Change in Accured Expenses (Quarter)								-0.10M		-0.11M	-0.23M	-0.09M
Misc.
Exchange Rate Effect (Quarter)	-0.84M									0.74M	-0.03M
Free Cash Flow (Quarter)								-1.87M		-8.97M	-8.30M	-5.79M
Net Cash Flow (Quarter)								-1.87M		-8.97M	-8.30M	-5.79M